CD9 and posterior cortical atrophy: Furthermore, uEVEpCAM-CD9 from nine randomly selected donors including five PCa and four HDs was assayed by the CLIA and WB, which suggested a significant elevation of uEVEpCAM-CD9 in PCa compared with HD (Figure 3E and Supplementary Figures S2C, D).